Age
Item
Ages Eligible for Study: 18 Years and older (Adult, Senior)
boolean
C0001779 (UMLS CUI [1])
Asthma or COPD
Item
Male and female adult patients with clinical diagnosis of bronchial asthma or chronic obstructive pulmonary disease
boolean
C0004096 (UMLS CUI [1])
C0024117 (UMLS CUI [2])
Inhaled corticosteroids and long-acting beta-2-agonists
Item
Patients on regular medication with inhaled corticosteroids and long-acting beta-2-agonists in fixed-dose combination
boolean
C2065041 (UMLS CUI [1])
C0001644 (UMLS CUI [2,1])
C0205166 (UMLS CUI [2,2])
Change of medication
Item
Patients who recently changed medication to DuoResp® Spiromax or are about to do so
boolean
C0580105 (UMLS CUI [1])
Informed Consent
Item
Capacitated person with present declaration of consent
boolean
C0021430 (UMLS CUI [1])
Contraindication
Item
Diseases contraindicated in accordance with the summary of product characteristic
boolean
C1301624 (UMLS CUI [1])
Study Participation Status
Item
Patients who take part in interventional clinical trials parallel or during the last 4 weeks
boolean
C2348568 (UMLS CUI [1])
Comorbidity
Item
Patient shows conditions or diseases that might disturb the monitoring according to the physician
boolean
C0009488 (UMLS CUI [1])
Substance Use Disorder
Item
Patients with substance misuse in their case history (drugs, alcohol) or with other factors (e.g. serious psychiatric conditions) that limit their ability to participate in the study
boolean
C2702800 (UMLS CUI [1])
Language Ability
Item
Insufficient German language knowledge to understand the patient education and to complete the questionnaires in a correct manner
boolean
C1145677 (UMLS CUI [1])
Study planning
Item
Patients involved in the planning and construction of the study (Teva staff and employees of the centres)
boolean
C0681871 (UMLS CUI [1])
Incapable of giving informed consent
Item
Patient is incapable of giving consent
boolean
C0021430 (UMLS CUI [1,1])
C1550518 (UMLS CUI [1,2])